代谢综合征和慢性阻塞性肺病之间的遗传关联和潜在的媒介:孟德尔的随机化研究
1The First Clinical College of Shandong University of Traditional Chinese Medicine, Jinan, China.
Medicine
|March 13, 2026
概括
代谢综合征 (MetS) 因果性地增加了慢性阻塞性肺病 (COPD) 的风险,主要是通过体重指数 (BMI). 在MetS患者中管理肥胖和高血压可能有助于预防COPD.
科学领域:
- 遗传学 是一个遗传学.
- 流行病学 流行病学
- 肺部病理学 肺部病理学
背景情况:
- 代谢综合征 (MetS) 和其组成部分与慢性阻塞性肺病 (COPD) 风险有关.
- 观察性研究存在局限性,导致因果关系和机制不清楚.
研究的目的:
- 通过使用孟德尔随机化 (MR) 调查MetS,其组成部分和COPD之间的因果关系.
- 探索MetS-COPD关联背后的调解机制.
主要方法:
- 两个样本的孟德尔随机化 (MR) 使用大型全基因组关联研究联盟.
- 单变和多变MR (MVMR) 分析.
- 两个步骤的MR评估调解.
主要成果:
- 基因预测的MetS显著增加了COPD风险 (OR=1.53).
- 高血压和腰围是关键因素;更高的禁食葡萄糖显示有保护作用.
- 身体质量指数 (BMI) 被确定为MetS和腰围对COPD影响的主要调解者 (86-94%).
结论:
- 超常态疾病,特别是肥胖和高血压,因果性地增加了COPD的风险.
- 体重指数 (BMI) 是从METS到COPD的途径中的关键调解者.
- 体重管理策略可能有效地预防COPD患者.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.3K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
93
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
93
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Chronic Obstructive Pulmonary Disease
2.9K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.9K

